Clinical Trials for Gastroesophageal Junction Cancer

A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.

NCT ID: NCT05322577

This clinical trial is studying a new treatment called bemarituzumab, which will be given alongside other cancer therapies for patients with advanced gastric (stomach) or gastroesophageal junction ...

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

NCT ID: NCT06731478

This clinical trial is exploring a new treatment approach for adults with advanced HER2-positive gastric or gastroesophageal junction (GEJ) cancer. Researchers want to see if a combination of three...

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

NCT ID: NCT06219941

This clinical trial is studying a new treatment called AZD0901 for patients with advanced solid tumors that express a protein known as Claudin18.2. The trial aims to find out how safe and effective...

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

NCT ID: NCT06346392

This clinical trial is studying a new treatment called AZD0901 for patients with advanced or metastatic gastric cancer or gastroesophageal junction cancer that expresses a specific protein known as...

Study for AZD4360 in Participants With Advanced Solid Tumours

NCT ID: NCT06921928

This clinical trial is investigating a new treatment called AZD4360 for adults with advanced solid tumors, specifically those diagnosed with gastric cancer, gastroesophageal junction cancer, biliar...

A Study of Treatment Patterns in HER2-positive Unresectable and Advanced Gastric/ Gastroesophageal Junction Cancer in China

NCT ID: NCT06585501

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

NCT ID: NCT05187182

This clinical trial is studying a new treatment called CA-4948, combined with standard chemotherapy and immunotherapy, for patients with advanced gastric and esophageal cancers that cannot be surgi...

Safety and Efficacy of Pembrolizumab in Combination With FLOT About Gastroesophageal Junction Cancer:

NCT ID: NCT06411171

This clinical trial is studying the safety and effectiveness of a treatment called Pembrolizumab when used together with a chemotherapy regimen known as FLOT for patients with gastroesophageal junc...

Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction

NCT ID: NCT06250894

This clinical trial is studying a new treatment approach for patients with locally advanced adenocarcinoma of the esophagogastric junction, which is a type of cancer that occurs where the esophagus...